Javascript must be enabled to continue!
Identification of Heat shock protein family A member 5 (HSPA5) targets involved in nonalcoholic fatty liver disease
View through CrossRef
Abstract
Background
HSPA5 is an endoplasmic reticulum chaperone which regulates cell metabolism, especially lipid metabolism. There are many reports about the role of HSPA5 in regulating cell function but the role on HSPA5 binding to RNA and its biological function in nonalcoholic fatty liver disease is still lacking.
Method
In the present study, the ability of HSPA5 to modulate the alternative splicing ( AS ) of cellular genes was assessed using RT-PCR on 89 nonalcoholic fatty liver disease-associated genes. RNA immunoprecipitation coupled to RNA sequencing (RIP-Seq) assays were also performed to identify cellular mRNAs bound by HSPA5.
Results
Upon HSPA5 expression, we detected modifications to the AS profiles of 89 genes involved in nonalcoholic fatty liver disease. Moreover, we show that HSPA5 modulates the expression levels of various splicing factors such as EGFR, NEAT1, LRP1 and TGFß1 which are important for the pathology of nonalcoholic fatty liver disease. Finally, RNA immunoprecipitation coupled to RIP-Seq assays demonstrated that HSPA5 immuno-precipitates specific cellular mRNAs.
Conclusion
This is the first report demonstrating that HSPA5 protein modulates the AS profiles of genes important in nonalcoholic fatty liver disease and binds lncRNA and mRNA linked to nonalcoholic fatty liver disease.
Springer Science and Business Media LLC
Title: Identification of Heat shock protein family A member 5 (HSPA5) targets involved in nonalcoholic fatty liver disease
Description:
Abstract
Background
HSPA5 is an endoplasmic reticulum chaperone which regulates cell metabolism, especially lipid metabolism.
There are many reports about the role of HSPA5 in regulating cell function but the role on HSPA5 binding to RNA and its biological function in nonalcoholic fatty liver disease is still lacking.
Method
In the present study, the ability of HSPA5 to modulate the alternative splicing ( AS ) of cellular genes was assessed using RT-PCR on 89 nonalcoholic fatty liver disease-associated genes.
RNA immunoprecipitation coupled to RNA sequencing (RIP-Seq) assays were also performed to identify cellular mRNAs bound by HSPA5.
Results
Upon HSPA5 expression, we detected modifications to the AS profiles of 89 genes involved in nonalcoholic fatty liver disease.
Moreover, we show that HSPA5 modulates the expression levels of various splicing factors such as EGFR, NEAT1, LRP1 and TGFß1 which are important for the pathology of nonalcoholic fatty liver disease.
Finally, RNA immunoprecipitation coupled to RIP-Seq assays demonstrated that HSPA5 immuno-precipitates specific cellular mRNAs.
Conclusion
This is the first report demonstrating that HSPA5 protein modulates the AS profiles of genes important in nonalcoholic fatty liver disease and binds lncRNA and mRNA linked to nonalcoholic fatty liver disease.
Related Results
Hubungan Perilaku Pola Makan dengan Kejadian Anak Obesitas
Hubungan Perilaku Pola Makan dengan Kejadian Anak Obesitas
<p><em><span style="font-size: 11.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-langua...
On Flores Island, do "ape-men" still exist? https://www.sapiens.org/biology/flores-island-ape-men/
On Flores Island, do "ape-men" still exist? https://www.sapiens.org/biology/flores-island-ape-men/
<span style="font-size:11pt"><span style="background:#f9f9f4"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><spa...
Hepatitis C Virus E2—Host Cell Receptor, HSPA5, Binding Site Prediction
Hepatitis C Virus E2—Host Cell Receptor, HSPA5, Binding Site Prediction
Hepatitis C Virus (HCV) is the main causative factor for liver cirrhosis and the development of liver cancer, with a confirmed ~ 180 million infections worldwide. E2 is an HCV stru...
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Background and Introduction: Non-alcoholic fatty liver disease (NAFLD) has been demonstrated that insulin resistance and metabolic syndrome are associated with non-alcoholic fatty ...
Heat shock protein Grp78/BiP/HspA5 binds directly to TDP-43 and mitigates toxicity associated with disease pathology
Heat shock protein Grp78/BiP/HspA5 binds directly to TDP-43 and mitigates toxicity associated with disease pathology
AbstractAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no cure or effective treatment in which TAR DNA Binding Protein of 43 kDa (TDP-43) abnormally ...
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
Objective:
This preliminary investigation aimed to assess the value of two elastography techniques, sound touch elastography (STE) and sound touch
quantification (STQ), in measurin...
Heat Shock Protein Grp78/BiP/HspA5 Binds Directly to TDP-43 and Mitigates Toxicity Associated with Neurodegenerative Disease Pathology
Heat Shock Protein Grp78/BiP/HspA5 Binds Directly to TDP-43 and Mitigates Toxicity Associated with Neurodegenerative Disease Pathology
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no cure or effective treatment in which TAR DNA Binding Protein of 43 kDa (TDP-43) ab...
Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study
Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study
Objective. The aim of study was to evaluate the effect and safety of pioglitazone-metformin combined treatment in the newly diagnosed type 2 diabetes patients with nonalcoholic fat...


